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Certain pathogenic bacteria adopt an intracellular lifestyle and proliferate in eukaryotic
host cells. The intracellular niche protects the bacteria from cellular and humoral
components of the mammalian immune system, and at the same time, allows the
bacteria to gain access to otherwise restricted nutrient sources. Yet, intracellular
protection and access to nutrients comes with a price, i.e., the bacteria need to
overcome cell-autonomous defense mechanisms, such as the bactericidal endocytic
pathway. While a few bacteria rupture the early phagosome and escape into the
host cytoplasm, most intracellular pathogens form a distinct, degradation-resistant
and replication-permissive membranous compartment. Intracellular bacteria that form
unique pathogen vacuoles include Legionella, Mycobacterium, Chlamydia, Simkania,
and Salmonella species. In order to understand the formation of these pathogen niches
on a global scale and in a comprehensive and quantitative manner, an inventory of
compartment-associated host factors is required. To this end, the intact pathogen
compartments need to be isolated, puriﬁed and biochemically characterized. Here, we
review recent progress on the isolation and puriﬁcation of pathogen-modiﬁed vacuoles
and membranes, as well as their proteomic characterization by mass spectrometry and
different validation approaches. These studies provide the basis for further investigations
on the speciﬁc mechanisms of pathogen-driven compartment formation.
Keywords: Chlamydia, host-pathogen interactions, immuno-magnetic puriﬁcation, Legionella, Mycobacterium,
Salmonella, Simkania, pathogen vacuole
Introduction
Proteomics of Pathogen-Host Interactions
Mass spectrometry (MS)–based proteomics is a powerful technology, allowing the identiﬁcation
and quantiﬁcation of hundreds of proteins from a single sample (Aebersold and Mann, 2003; Otto
et al., 2014). This technique has been employed successfully in a diverse range of areas, including
the impact of environmental stressors (Maass et al., 2014; Wenzel et al., 2014), conditions of health
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and disease (Hofmann et al., 2010; Hansmeier et al., 2012;
Kopecka et al., 2015; Lassek et al., 2015) or determinants of
bacterial and eukaryotic physiology (Cravatt et al., 2007; Trost
et al., 2009; Chao et al., 2010; Picotti et al., 2013; Kohlmann
et al., 2014). Over the last years, pathogen-host-interactions were
increasingly addressed by proteome studies (Becker et al., 2006;
Mattow et al., 2006; Rogers and Foster, 2008; Urwyler et al.,
2009; Li et al., 2010; Ansong et al., 2013; Claudi et al., 2014;
Hoﬀmann et al., 2014b), summarized in reviews by Bumann
(2010), Hartlova et al. (2011), Schmidt and Völker (2011) and
Steinert (2011).
A major challenge of studies in the ﬁeld of pathogen-
host interaction is the limited material available from infection
settings. In addition, bacterial proteins are vastly outnumbered
by host proteins that may not be involved in the infection process.
Hence, “-omics” studies are dealing with at least two diﬀerent
organisms combined in a single analytical setting. Consequently,
the diﬃculty lies in targeting either host proteins or pathogen
virulence factors individually or both at the same time in
comparative studies (Hartlova et al., 2011) with potentially very
asymmetric ratios of protein abundance (Schmidt and Völker,
2011). This problem can only be met with methods that are
sensitive and provide a wide dynamic range.
An even greater challenge is the targeted analysis of pathogen-
containing host compartments. These fragile organelle-like
microenvironments represent the direct contact region between
the pathogens and their hosts. However, attempts to purify these
compartments using classical organelle enrichment techniques
were not very successful. Recently, combinations of classical
and improved enrichment and pre-fractionation strategies
resolved this problem (see chapters below) and enabled for
the ﬁrst time proteomics surveys of those delicate intracellular
compartments.
Gel-Based Proteomics
The call for global overviews of infection processes on protein
level has introduced classical 2D gel-based proteomics early to
the ﬁeld, and it has still kept its place for targeting soluble
proteomes (Figure 1). Starting with only a limited number
of proteins detected (Desjardins et al., 1994), the analytical
depth of global proteome studies has increased markedly by
technical developments in 2D gel-based proteomics (Shevchuk
et al., 2009). Classical gel-based (i.e., “top-down”) proteomics
uses two physicochemical properties, the pI and the molecular
weight, to orthogonally resolve soluble proteins. This is achieved
by isoelectric focusing (IEF) followed by SDS-PAGE leading
to highly resolved 2D gels. Staining of the protein spots
and diﬀerential comparison of gel images then allows for a
relative quantiﬁcation across diﬀerent proteome samples based
on protein abundances.
Following spots detection, resolved proteins are identiﬁed
by state-of-the-art MS techniques, such as matrix-assisted laser
desorption ionization time of ﬂight (MALDI-TOF). It is possible
to resolve more than a thousand protein spots with up to
700 diﬀerent proteins by 2D gel-based proteomics. With recent
improvements in the second dimension, an increase of detected
protein by 25% was achieved (Moche et al., 2013). Despite
these improvements, gel-based proteomics suﬀers from detection
limitations due to protein hydrophobicity, abundance and
extreme physicochemical properties.
Gel-Free Proteomics
The limitations of gel-based proteomics have led to the
introduction of liquid chromatography (LC)-MS-based, gel-free
proteomics techniques. This has revolutionized the ﬁeld, in
terms of sensitivity and versatility, e.g., allowing to also target
membrane proteomes in large scale studies (Aebersold and
Mann, 2003; Cravatt et al., 2007; Trost et al., 2009). Gel-free
proteomics changed the focus of the analytical setting from
the proteins toward proteolytic peptides generated from the
samples under investigation (Duncan et al., 2010). In “bottom-
up” proteomics, protein samples are ﬁrst digested by speciﬁc
proteases, mostly trypsin, and the resulting very complex digests
are subjected to LC. The peptides are typically loaded on reversed
phase columns, desalted and then eluted according to their
hydrophobicity by a binary gradient of water/organic solvent.
On eluting from the LC-column, the peptides are ionized by
electrospray ionization, and mass/charge ratios are determined
by MS. The peptides are identiﬁed by stochastically sampling
the fragment pool, allowing for an unambiguous identiﬁcation
using database searching tools and available sequence databases
(Figure 1). This approach is entirely MS-centered, and thus,
technology development increasingly determined the sensitivity
attained, the protein groups amenable for analyses (membrane
proteins, small proteins, basic proteins) and the sheer number or
proteins identiﬁed.
In contrast to gel-based proteomics, which is regarded as
being inherently quantitative, MS-based proteomics approaches
are lacking this feature. For diﬀerential comparisons most semi-
quantitative workﬂows either depend on the introduction of
isotope labels at diﬀerent stages of sample preparation, both
in vivo or in vitro (metabolic labeling by stable isotope labeling
or chemical labeling), or they are label-free and based on
for instance “spectral counting” or “area under the curve”
determination on the MS1 level (Zybailov et al., 2006; Neilson
et al., 2011). Arguably, any in vivo stable isotope labeling
technique (e.g., SILAC, 15N labeling) is superior to other gel-
free quantiﬁcation techniques, but this requires a suitable and
redundant biological system that makes labeling at the metabolic
level possible (Porteus et al., 2011). However, for the investigation
of infection processes, the introduction of stable isotopes by
metabolic labeling is challenging; for instance, the simultaneous
labeling of host and pathogen is often not possible, thus limiting
this approach so far to only deﬁned analytical settings in early
stages of infection (Schmidt and Völker, 2011).
A striking feature of gel-free proteomics approaches is the
superb sensitivity of high resolution and accurate massMS. Using
this technological advances, it has become possible to investigate
host compartments for the presence and composition of host
and pathogen proteins, and to elucidate the dynamics of their
interactions, as well as to explore post-translational modiﬁcations
relating to the infection process (Bruckert and Abu Kwaik, 2014).
This will be an intense research ﬁeld in infection biology in the
upcoming years.
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FIGURE 1 | MS-based workﬂow of two basic proteomic approaches
(gel-based vs. gel-free) to resolve the proteome of
pathogen-containing host compartments. Infected cells were
harvested and lysed by chemical or mechanical treatment.
Pathogen-containing host compartments were enriched by combinations
of density gradient (DG) centrifugation, afﬁnity immuno-precipitation (IP)
and ﬂuorescence-activated cell sorting (FACS). Isolated host
compartments were then either ﬁrst enzymatically digested (gel-free),
followed by LC-based peptide separation, or ﬁrst separated by 2D-PAGE
followed by individual protein digests, before MS analyses. The data are
processed to determine and/or quantify the peptide amino acid sequence
through database searches.
Subcellular Pathogen Compartments
As a pathogen is residing in a speciﬁc compartment in the
host, the ﬁrst step for most proteome studies in this ﬁeld
comprises selective enrichment of pathogen-containing vacuoles
(PCVs) or internalized bacteria. This may be achieved by
subcellular/organellar fractionation based on physicochemical
properties (Howe andHeinzen, 2008; He et al., 2012; Cheng et al.,
2014), by immuno-aﬃnity puriﬁcation (Urwyler et al., 2010;
Hoﬀmann et al., 2013; Vorwerk et al., 2015), or through single
cell FACS enrichment by sorting internalized bacteria and lysed
host cells/organelles (Becker et al., 2006; Pförtner et al., 2013;
Surmann et al., 2014). These approaches greatly reduce sample
complexity in proteomics approaches and increase the speciﬁcity
and the quality of conclusions that can be drawn from the data.
For all steps performed during sample preparation, it is
crucial to verify the speciﬁcity of the chosen approach in
order to minimize artifacts caused by co-puriﬁed “contaminant”
organelles, which are meaningless for the biological setting
under investigation (Rogers and Foster, 2007; Shevchuk et al.,
2009; Hoﬀmann et al., 2014a; Vorwerk et al., 2015). Following
this enrichment/puriﬁcation step, any temporal or spatial
rearrangement of proteins can be queried by proteomic analytical
techniques relying on the aforementioned quantitative or at least
semi-quantitative methods (Otto et al., 2014).
Here, we review recent progress on the isolation and
puriﬁcation of pathogen-modiﬁed vacuoles and membranes
from host cells infected with obligate or facultative intracellular
bacteria. To this end, we focus on and compare membrane
compartments modiﬁed by Legionella, Chlamydia, Simkania, or
Salmonella spp., respectively, or phagosomes containing beads
coated with distinct cell wall lipids puriﬁed fromMycobacterium
tuberculosis. The proteomic characterization of these unique
pathogen niches by MS represents a comprehensive approach
toward a detailed understanding of these compartments and
provides the basis for further investigations on the speciﬁc
mechanisms of pathogen-driven compartment formation and
direct or indirect interactions of pathogen and host factors.
Intracellular Vacuolar Pathogens
Legionella pneumophila
Legionella spp. are ubiquitous environmental bacteria that upon
inhalation cause a severe pneumonia named “Legionnaires’
disease” (Newton et al., 2010; Hilbi et al., 2011a). The
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opportunistic pathogen colonizes a variety of niches in the
environment; yet, a peculiar trait of the bacteria is their amoebae-
resistance (Hoﬀmann et al., 2014b). By employing an apparently
conserved mechanism, the Gram-negative bacteria replicate
intracellularly in free-living protozoa as well as in mammalian
macrophages within a unique compartment, the “Legionella-
containing vacuole” (LCV) (Figure 2). LCVs restrict the fusion
with lysosomes and do not acidify, but extensively communicate
with the endosomal, secretory and retrograde vesicle traﬃcking
pathways and ﬁnally coalesce with the endoplasmic reticulum
(ER) (Isberg et al., 2009; Hilbi and Haas, 2012).
Intracellular replication and LCV formation of Legionella
pneumophila (Lpn) requires a bacterial type IV secretion system
(T4SS) called Icm/Dot (intracellular multiplication/defective
organelle traﬃcking), which transports “eﬀector” proteins into
host cells, where they subvert host vesicle traﬃcking and
signal transduction pathways (Nagai and Kubori, 2011). For
Lpn, approximately 300 diﬀerent Icm/Dot substrates have been
experimentally validated (Hubber and Roy, 2010; Zhu et al.,
2011; Lifshitz et al., 2013), some of which subvert small GTPases
of the Arf, Rab, or Ran family (Hubber and Roy, 2010; Itzen
and Goody, 2011; Rothmeier et al., 2013; Sherwood and Roy,
2013; Simon et al., 2014), the vacuolar H+-ATPase (Xu et al.,
2010), the autophagy machinery (Choy et al., 2012), the retromer
complex (Finsel et al., 2013b) or phosphoinositide (PI) lipids
(Weber et al., 2009; Hilbi et al., 2011b; Haneburger and Hilbi,
2013). E.g., several Lpn eﬀectors anchor to the LCV membrane
by speciﬁcally binding to the PI lipid phosphatidylinositol 4-
phosphate (PtdIns(4)P) present on the pathogen vacuole together
with the phosphatidylinositol 5-phosphatase OCRL1 (Weber
et al., 2006, 2014; Ragaz et al., 2008; Brombacher et al., 2009).
Thus, Lpnmodulates in a sophisticated and very speciﬁc manner
a plethora of host processes to custom-tailor its intracellular
replicative niche.
Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb), the agent of human
tuberculosis (TB), is a facultative intracellular pathogen in
phagocytes. Upon inhalation, Mtb is engulfed by alveolar
macrophages (MO) as ﬁrst line of defense against inhaled
pathogens and initiator of host responses to infection.
Subsequently, alveolar MO and lung epithelial cells release
chemokines including interleukin (IL)-8, thereby amplifying
local inﬂammation by attracting monocyte-derived MO and
polymorphonuclear neutrophils (PMN). These cells take their
share in engulﬁng Mtb, as do tissue resident dendritic cells
FIGURE 2 | Biogenesis of pathogen vacuoles. Legionella,
Mycobacterium, Chlamydia, Simkania, and Salmonella spp. form distinct
pathogen-containing vacuoles. Abbreviations: CCV, Chlamydia-containing
vacuole; CERT, ceramide transfer protein; ER, endoplasmic reticulum;
ERGIC, ER-Golgi intermediate compartment; EE, early (sorting) endosomes;
LE, late endosomes; LCV, Legionella-containing vacuole; MCV,
Mycobacterium-containing vacuole; PM, plasma membrane; SCV,
Salmonella-containing vacuole; SIF, Salmonella-induced ﬁlament; SMM,
Salmonella-modiﬁed membranes; SKIP, SifA and kinesin interacting protein;
SnCV, Simkania-containing vacuole. LCVs intersect with the secretory
pathway between ER exit sites and the cis-Golgi network and also interact
with the retrograde recycling pathway. MCVs represent maturation-stalled
endosomal compartments. Chlamydia “elementary bodies” (EBs) form
between the TGN and the PM a membrane-bound “inclusion” (CCV), which
communicates with the Golgi apparatus and wherein EBs differentiate into
“reticulate bodies” (RBs). SnCVs also interact with the Golgi as well as with
perinuclear ER and mitochondria. SCVs extensively interact with lysosomes
and eventually localize to the peri-Golgi region. For details see text.
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(DC), which deliver antigenic cargo to the draining lymph
nodes in order to prime speciﬁc T cells. Mtb induces the release
of pro-inﬂammatory cytokines by MO and DC, which bias
T cell immunity toward Th1 cell responses, as characterized
by generation of the pro-inﬂammatory and MO-activating
cytokines, interferon gamma (IFN-γ) and tumor necrosis factor
alpha (TNF-α) (O’Garra et al., 2013). As prime host cells, the
resting MO allows intracellular survival and proliferation ofMtb,
whereas immune activated MO, PMN or DC are not permissive
for pathogen growth (Corleis et al., 2012; Weiss and Schaible,
2015). However, despite these early host defense measures,
Mtb is able to establish infection, which can be contained
in more than 90% of all cases at a latent stage but bears the
risk of reactivation and development of active TB later in life
(Koul et al., 2011).
As Mtb fails to actively enter host cells, the bacteria require
phagocytosis to reach their intracellular niche, which is facilitated
by an array of germ-line encoded innate host cell receptors
including C-type lectins such as the macrophage mannose
receptor (MMR), MCL and DC-SIGN. Upon opsonization by
complement or speciﬁc antibodies, CR3 and FcR are also
involved in Mtb uptake. Simultaneous triggering of Toll-like
receptors (TLR-1/2 heterodimers, TLR-9) and other pattern
recognition receptors such as Mincle and Dectin-2 perpetuate
and enhance inﬂammatory responses, which in part can
limit mycobacterial growth (Tanne and Neyrolles, 2011). MO
activation by IFN-γ and TNF-α promotes expression of genes
encoding anti-microbial peptides, nitric oxide synthase (NOS2)
and LRG47, which directly attack the mycobacteria or mediate
microbicidal eﬀector mechanisms, including generation of toxic
nitric oxide and oxygen intermediates, host cell apoptosis and
autophagy, respectively, and subsequent control of Mtb (Weiss
and Schaible, 2015).
Upon phagocytosis, virulent Mtb converts the newly
formed phagosome into a replication-permissive niche, the
Mycobacterium-containing vacuole (MCV; Figure 2), thereby
exploiting the host cell’s endosomal system and metabolism to
its own beneﬁt and, at the same time, escaping humoral host
defense mechanisms such as speciﬁc antibodies and complement
(Russell, 2011;Weiss and Schaible, 2015).Mtb arrests phagosome
maturation at an early endosomal stage, as characterized by an
almost neutral pH of 6.3, due to limited numbers of the proton-
pumping vacuolar ATPase and low concentrations of LAMP-1
and active lysosomal hydrolases (de Chastellier, 2009; Russell,
2011). Furthermore, the Mtb phagosome carries the actin-
binding coat protein, coronin 1, and acquires iron-saturated
holotransferrin (TF), which is delivered through the TF receptor.
One beneﬁt of residing in a non-maturing early endosomal
phagosome is probably that Mtb can access the host cell’s iron
import pathway to satisfy the pathogen’s need for iron (Weiss and
Schaible, 2015). Nevertheless, virulent Mtb can resist lysosomal
conditions, though optimal replication may be hindered in the
hostile low pH environment in the phago-lysosome (Ehrt et al.,
2015). It has also been reported that virulentMtb can disrupt the
phagosomal membrane and escape into the cytoplasm (van der
Wel et al., 2007; Simeone et al., 2012), which adds an additional
strategy to the virulence properties of this successful and well
host-adapted pathogen.
Mtb produces several secreted proteins interfering with
phagosome maturation. These include Ndk, PtpA and
PE_PGRS30. Ndk dephosphorylates and inhibits recruitment
of Rab7-GTP and Rab5-GTP to phagosomes (Forrellad et al.,
2013). PtpA dephosphorylates VPS33B, a host protein involved
in regulation of membrane fusion, and binds to the vacuolar
H+-ATPase thereby interfering with luminal acidiﬁcation. The
role of PE_PGRS30 is not known although its deletion drives
mutant Mtb into phago-lysosomes (Forrellad et al., 2013).
Recently, the secreted acid phosphatase SapM was found to
dephosphorylate phosphatidyl-inositol 3-phosphate (PtdIns3P)
located at the cytoplasmic sheet of the phagosomal membrane
and essential for progression of phagosome biogenesis (Vergne
et al., 2005).
Components of the complex mycobacterial cell wall have also
been identiﬁed as virulence factors, which can deviate phagosome
maturation. Examples are mannose-capped lipoarabinomannan
(ManLAM), phosphatidyl-inositol mannosides (PIMs) and, most
importantly, the cord factor, trehalose-6,6-dimycolate (TDM)
(Indrigo et al., 2002; Fratti et al., 2003; Vergne et al., 2003; Kang
et al., 2005; Axelrod et al., 2008).
Chlamydia and Simkania spp.
Chlamydia spp. are a major cause of sexually transmitted,
pulmonary and ocular diseases in humans worldwide. Recently,
other chlamydia-like organisms like Simkania negevensis (Sn)
and Waddlia chondrophila (Wc) were described to have
pathogenic properties as well (Corsaro and Greub, 2006;
Baud et al., 2015). Members of the order Chlamydiales
are characterized by four particular features: (1) obligate
intracellular lifestyle, (2) Gram-negative-related cell wall, (3)
coccoid morphology and (4) bi-phasic developmental cycle.
Infection of the eyes by Chlamydia trachomatis (Ctr) serotypes
A-C might lead to chronic conjunctivitis (trachoma) resulting
in preventable blindness if untreated, whereas infection of
the urogenital tract by serotypes D-L can cause prostatitis,
pelvic inﬂammatory disease and an increased risk of ectopic
pregnancy or infertility in women. Chlamydophila pneumoniae
(Cpn) and Chlamydophila psittaci (Cps) infect the upper
respiratory tract and represent community-acquired or animal-
transmitted pathogens. Acute infections cause pneumonia or
chronic bronchitis and could lead to chronic asthma (Hahn
and McDonald, 1998; Harkinezhad et al., 2009). In contrast to
Ctr, Cpn and Cps can infect animals like koalas, birds, bovines,
musquashs and snails.
Sn has a broad host spectrum besides humans and can grow
in amoebae and in several human or simian epithelial cell
lines or macrophages (Kahane et al., 2007) as well as in insect
cells (Sixt et al., 2012). Infection with Sn has been connected
to upper respiratory tract infections in humans, and manifests
as community acquired pneumonia (CAP), bronchiolitis or
chronic obstructive lung diseases (Lieberman et al., 2002), and to
granuloma formation in reptiles (Soldati et al., 2004). Infections
of the lower respiratory tract caused by Ctr, Sn, andWc have been
connected tomiscarriages and premature births (Greenberg et al.,
2003; Baud et al., 2015).
The life cycles of Sn and Ctr are similar and consist of two
developmental stages. Infection is initiated by endocytosis of
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so-called elementary bodies (EB). Inside the membrane-bound
endosomal compartment, EB diﬀerentiate into metabolic active
reticulate bodies (RB) that replicate by binary ﬁssion in this
Chlamydia-speciﬁc compartment called inclusion or Chlamydia-
containing vacuole (CCV; Figure 2). Finally, RB re-diﬀerentiate
into EB that are released by cell lysis or extrusion and start a
new infection cycle in surrounding cells (for a review see Bastidas
et al., 2013).
The Ctr surface proteins OmcB and MOMP mediate
adherence to surface receptors of eukaryotic cells that trigger
endocytic uptake by host cells (for a review see Mehlitz and
Rudel, 2013). This process requires a functional type III secretion
system (T3SS) (reviewed by Mueller et al., 2014) to secrete
eﬀector proteins, like TARP and CT694, into the host cytosol to
modulate the cytoskeleton (for a review see Mehlitz and Rudel,
2013) or lipid transport (reviewed by Elwell and Engel, 2012).
The pathogen-containing endosome matures then to CCV by
preventing phago-lysosomal fusion and manipulation of host
traﬃcking pathways for nutrient acquisition (Stephens et al.,
1998).
Critical mediators of membrane traﬃcking like Rab1,
Rab4, Rab6 and Rab11 (Rzomp et al., 2003; Capmany and
Damiani, 2010) are recruited to inclusion membranes, e.g.,
by direct binding to chlamydial inclusion membrane (Inc)
proteins (Rab4-CT229) (Moorhead et al., 2007) or by so far
unknown mechanisms (Rab6-BICD1) (Moorhead et al., 2010).
These Rab proteins support Ctr infectivity and replication
(Rejman Lipinski et al., 2009; Capmany and Damiani, 2010).
The phosphatidylinositol 5-phosphatase OCRL1 is recruited
to the CCV in a Rab-dependent manner to modify the
parasitophorous vacuole by production of PtdIns(4)P (Moorhead
et al., 2010). Additional host factors like Arf1 and PI4KIIα are
recruited to provide PtdIns(4)P synthesis at the Golgi apparatus.
Lipid acquisition (cholesterol, sphingomyelin) is connected to
transport of Golgi-derived exocytic vesicles (Carabeo et al., 2003),
multivesicular bodies (MVBs) (Beatty, 2006, 2008) and to non-
vesicular transport via membrane contact sites to the ER (e.g.
CERT-dependent) (Derre et al., 2011; Elwell et al., 2011).
Although the chlamydial inclusion seems to build a single
compartment in the cytosol, it interacts with multiple subcellular
compartments (Golgi, ER, lipid droplets, mitochondria, and
recycling endosomes) to acquire nutrients for successful
intracellular replication. Sn encodes a functional T3SS as well
as T4SS and actively interferes with pro-apoptotic signaling
as well as ER stress (Collingro et al., 2011; Mehlitz et al.,
2014). In contrast to the CCV, the Simkania-containing vacuole
(SnCV; Figure 2) represents an inhomogeneous compartment
that develops multiple ER-contact sides. Thereby, the vacuole
seems to grow along the rough and smooth ER (Mehlitz et al.,
2014).
Salmonella enterica
Salmonella enterica (Sen) is a food-borne Gram-negative
pathogen causing a high number of infectious diseases ranging
from localized, self-liming gastroenteritis to systemic, life-
threatening typhoid fever. Salmonella spp. are invasive,
facultative intracellular pathogens residing in a unique
membrane-bound compartment, termed Salmonella-containing
vacuole or SCV (Haraga et al., 2008) (Figure 2). Within the SCV,
the pathogen deploys the SPI2-encoded type III secretion system
(SPI2-T3SS) to translocate eﬀector proteins that manipulate
various host cell functions, including vesicular transport and
the organization of the endosomal system (Ibarra and Steele-
Mortimer, 2009; Rajashekar and Hensel, 2011; Figueira and
Holden, 2012). The SCV is considered a unique pathogen-
containing compartment that is derived from the pathway of
endosomal maturation. SCV markers include the lysosomal
glycoprotein LAMP1 as well as the small GTPase Rab7, and the
lumen of SCVs is thought to have a pH around 5.
The ability of Sen to survive within eukaryotic host cells is
closely linked to systemic pathogenesis. Mutant strains defective
in intracellular survival and replication such as SPI2-T3SS-
deﬁcient strains are highly attenuated in systemic disease models
of infection (Hensel et al., 1998). One dramatic consequence
of host manipulation is the induction of complex networks of
tubular membrane compartments, such as Salmonella-induced
ﬁlaments (SIF) that are characterized by the presence of late
endosomal/lysosomal membrane proteins (Garcia-del Portillo
et al., 1993). Recently, further Salmonella-induced tubular
compartments have been described in addition to SIF, termed
Salmonella-induced SCAMP3 tubules (SIST) and LAMP1-
negative tubules (LNT) (Schroeder et al., 2011). In order to
understand the intracellular lifestyle of Salmonella in mammalian
host cells, the characterization of the speciﬁc properties of the
SCV is a key issue.
Isolation and Puriﬁcation of Pathogen
Vacuoles and Membranes
Legionella-Containing Vacuoles
The LCV is a complex pathogen compartment formed by
continuous interactions with a variety of host cell organelles
and traﬃcking pathways. To enrich intact LCVs, we sought to
exploit the fact that some Icm/Dot T4SS substrates exclusively
localize to the pathogen compartment membrane. E.g., the
106 kDa Icm/Dot substrate SidC selectively anchors to the LCV
membrane (Luo and Isberg, 2004) and speciﬁcally binds to the
host cell PI lipid PtdIns(4)P via a C-terminal 20 kDa domain
termed “P4C” (PtdIns(4)P-binding of SidC) (Weber et al., 2006;
Ragaz et al., 2008; Brombacher et al., 2009; Dolinsky et al., 2014).
Using an aﬃnity-puriﬁed polyclonal anti-SidC antibody, we
established a straight-forward two-step protocol to isolate intact
LCVs from Lpn-infected Dictyostelium discoideum amoebae
(Urwyler et al., 2010; Finsel et al., 2013a) or murine macrophage-
like RAW 264.7 cells (Hoﬀmann et al., 2012, 2013) (Figure 3A).
The LCV puriﬁcation protocol is based on immuno-magnetic
separation followed by classical density gradient centrifugation,
and it allows monitoring the enrichment of pathogen vacuoles by
light microscopy using ﬂuorescently labeled Lpn and phagocytes.
To isolate LCVs from phagocytes, D. discoideum amoebae
producing the LCV/ER marker calnexin-GFP or RAW 264.7
macrophages were infected at a multiplicity of infection (MOI)
of 50 with Lpn producing the red ﬂuorescent protein DsRed
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FIGURE 3 | Puriﬁcation schemes of pathogen vacuoles and
pathogen-modiﬁed membranes. (A) Puriﬁcation of
Legionella-containing vacuoles (LCVs) from infected (1 h) D.
discoideum or RAW 264.7 macrophages by immuno-magnetic
separation using an anti-SidC antibody, followed by Histodenz
density gradient centrifugation. (B) Enrichment of Mycobacterium
TDM-bead phagosomes by magnetic puriﬁcation, Ficoll density
gradient centrifugation and FACS sorting. RAW 264.7
macrophages exposed to TDM-beads were lysed after 30min,
and phagosomes were isolated (DynaMag magnet), followed by
density gradient centrifugation, DNase and gentle protease
treatment, and ﬁnally by sorting via FACS. Isolation of (C)
Chlamydia-containing vacuoles (CCVs) or (D) Simkania-containing
vacuoles (SnCVs) were separated by differential centrifugation.
Ctr-infected HeLa cells (24 h) were washed, trypsinised,
resuspended in swelling buffer and lysed with a Dounce
homogenizer, followed by double ﬁltration. Sn-infected HeLa cells
(72 h) were scraped, resuspended in swelling buffer, lysed with
a Douncer and an ultrasonic bath, followed by sequential
centrifugation. (E) Enrichment of fractionated Salmonella-modiﬁed
membranes (SMMs) using differential centrifugation followed by
immuno-precipitation (IP) with antibodies against the
epitope-tagged effector protein SseF. PNF, pre-nuclear fraction;
PMF, pre-mitochondrial fraction.
and incubated for 1 h at 25◦C (D. discoideum) or 37◦C
(macrophages). The infected phagocytes were washed with SorC
buﬀer (D. discoideum) or PBS (macrophages) and scraped
in osmo-stabilizing homogenization buﬀer (Derre and Isberg,
2004). Subsequently, the cells were homogenized using a stainless
steel ball homogenizer (8μm clearance; Isobiotec) and incubated
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with an anti-SidC antibody, followed by a secondary anti-
rabbit antibody coupled to magnetic beads. The LCVs in the
homogenate were separated in a magnetic ﬁeld using a MACS
multistand (Miltenyi Biotec) and further puriﬁed by Histodenz
density gradient centrifugation.
The puriﬁed LCVs thus obtained were analyzed by MS,
Western blot and immuno-ﬂuorescence microscopy (Hoﬀmann
et al., 2014a).Moreover, host and pathogen LCV factors identiﬁed
by MS were validated by ﬂuorescence microscopy of intact
infected cells, and their functional role for LCV formation was
assessed by using deﬁned Lpn or D. discoideum deletion mutants
or by RNA interference in epithelial cells (Rothmeier et al., 2013;
Hoﬀmann et al., 2014a; Simon et al., 2014).
Mycobacterium TDM-Beads Phagosomes
To characterize the virulence function of puriﬁed mycobacterial
cell wall lipids in Mtb phagosome biogenesis, a simpliﬁed
glycolipid-coated bead model was employed (Axelrod et al.,
2008; Geﬀken et al., 2015). This approach diﬀers from the
protocols described above for analysis of other pathogen-
containing vacuoles. The simpliﬁed “infection model” using
beads coated with TDM was employed to obtain puriﬁed
phagosomes that are determined by just one mycobacterial
virulence factor. This concept allowed to analyze better deﬁned
phagosomes in proteomics studies, and to establish a more
restricted TDM interactome, some candidates of which were
subsequently validated in theMtb-MO infectionmodel (Kolonko
et al., 2014).
In short, bovine-serum-albumin (BSA) was covalently linked
to magnetic polystyrene beads (Dynabeads, Dynal) via ester-
bonds facilitated by the tosyl-activated surface of the beads. The
lipid-binding capacity of BSA was employed to coat the beads
with puriﬁed cell wall glycolipids of Mtb. These beads were used
to mimic infection of MO to monitor phagosome biogenesis in
the presence or absence ofMtb glycolipids. After diﬀerent periods
of time, bead phagosomes were analyzed either by microscopy or,
upon puriﬁcation, by Western blot, lysosomal enzyme tests and
FACS. Thereby, we identiﬁed trehalose 6,6′-dimycolate (TDM),
an abundant mycobacterial cell wall glycolipid, as essential Mtb
virulence factor. TDM eﬃciently decelerates bead phagosome
maturation when coated to the bead surface (Axelrod et al., 2008).
Of note, intracellular mycobacteria show increased production
of TDM when compared to those grown in broth, indicating a
function of TDM in the intracellular phase ofMtb (Fischer et al.,
2001). Furthermore, using the reductionist lipid-on-bead model,
we revealed that the virulence function of TDM, i.e., decelerating
phagosome maturation, is abolished in IFN-γ-activated MO by
nitric oxide (Axelrod et al., 2008).
Considering TDM an essential virulence determinant of Mtb,
identiﬁcation of putative host target proteins is a prerequisite
to understand the function of the lipid in inhibiting phagosome
maturation. To achieve this task, we used a comparative
proteomics approach analyzing puriﬁed phagosomes containing
either control or TDM-coated beads. The procedure to purify
bead phagosomes from macrophages has been described in
detail (Geﬀken et al., 2015) (Figure 3B). Brieﬂy, RAW 264.7
macrophages were “bead-infected” using dynabeads covalently
coated with BSA and TDM, incubated for 30min at 37◦C and
scraped into ice-cold PBS. The pellets were then resuspended
in ice-cold homogenization buﬀer (HB) and disrupted using a
metal Douncer. Lysates were further pushed through a needle,
incubated with DNase I and washed in ice-cold PBS using the
DynaMag-2 magnet. To further remove cell-debris, samples were
digested with trypsin, washed three times with HB and loaded
onto a 15% Ficoll-gradient. Subsequently, the samples were
diluted in ice-cold PBS, sorted by FACS, and phagosomes were
collected by using a magnet. Remaining proteins in supernatants
were precipitated using “StrataClean Beads.”
The iron content of the beads was used for quantiﬁcation
of puriﬁed bead-phagosomes by determining iron-concentration
(Zhu et al., 2012). For quality control of bead-phagosome
preparations we used the lysosomal β-galactosidase assay as
described previously (Lührmann and Haas, 2000). Pairs of
FACS-puriﬁed control- or TDM-dynabead-phagosomes and
their corresponding StrataClean precipitated supernatants were
further processed for LC-MS/MS analysis. To determine the
phagosomal proteome, we used GeLCMS as described (Bonn
et al., 2014). In this approach, isolated proteins were gel-
separated before being subjected to tryptic digestion and RP-LC-
MS/MS analyses using an Orbitrap Elite coupled online to an
EASY-nLC 1000 (Thermo, Bremen).
Chlamydia and Simkania Inclusions
The knowledge of how Ctr can eﬀectively control the signaling
pathways and escape from the host cell death pathway depends
on the identiﬁcation and analysis of the host cell factors that
interact with the Ctr inclusion. To identify these host proteins,
a method for the native Ctr inclusion isolation was established
(Figure 3C). Inclusions were isolated and puriﬁed as previously
described (Matsumoto, 1981); yet, the protocol included several
modiﬁcations as outlined below. Since the puriﬁcation relies on
a double ﬁltration procedure, non-infected cells were used as a
control to eliminate proteins that pass the ﬁlters in absence of
inclusions.
HeLa cells were infected with Ctr at a MOI of 1 for 24 h.
After washing the cells twice with PBS, cells were treated with
trypsin and collected. Subsequently, cells were washed three
times with PBS, re-suspended in hypotonic swelling buﬀer and
kept on ice for 90min. Swollen cells were homogenized using
a glass Dounce homogenizer, ﬁltered (11μm nylon ﬁlter) and
centrifuged. The supernatant was passed through a second glass
membrane ﬁlter, centrifuged and washed twice. Further washing
and centrifugation steps were applied if debris was visible close
to the inclusion pellet. The pellet containing the inclusions was
ﬁnally re-suspended in sucrose-Tris buﬀer containing 5% BSA
and spun down. The puriﬁcation procedure was monitored by
phase contrast, confocal or electron microscopy and immuno-
blot analysis. Pure inclusions were enriched and seen abundantly
at the ﬁnal stage of puriﬁcation.
Through this approach, intact Ctr inclusions were obtained.
However, six dishes of cells were required to yield suﬃcient
amounts of puriﬁed inclusions. Further, around 40% of the
inclusions tended to break during puriﬁcation. Therefore, the
infected cells were used for inclusion preparation no longer
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than 24 h post infection (p.i.), since intact inclusions could
hardly be obtained after longer infection periods. The integrity
of inclusions was tested by analyzing inclusions containing GFP-
producing Chlamydia (Wang et al., 2011). Another caveat is that
weakly interacting host proteins may detach from the chlamydial
inclusion membrane during the puriﬁcation process, which leads
to the loss of candidate CCV host components.
In our previous work, we identiﬁed a direct association
of Simkania-containing vacuoles (SnCVs) with the ER of the
host (Mehlitz et al., 2014). It is currently unknown how ER-
SnCV interaction sites are established and how they may
aﬀect the composition of the ER. Therefore, we established
an ER-SnCV membrane puriﬁcation protocol (Herweg et al.,
in revision) (Figure 3D). ER membranes of non-infected cells
were used as control. Since no suitable targets for IP are known,
we performed sub-cellular fractionation instead of immuno-
magnetic separation. To this end, HeLa 229 or THP1 cells
were seeded in 6-well plates 24 h prior to infection with Sn.
The infected cells were harvested (3 days p.i.) by scraping.
Subsequently, the cells were swelled and lysed with a Dounce
homogenizer and ultrasonic bath resulting in the release of the
bacteria from SnCVs. ER-SnCV membranes were puriﬁed by
sequential centrifugation including ultracentrifugation. Since Sn
is not accessible to genetic modiﬁcations, bacteria or SnCVs
labeled with ﬂuorescent proteins could not be used to validate
the puriﬁcation process. The loss of intact bacteria as well
as the puriﬁcation of ER-SnCV membranes thus had to be
monitored using transmission electron microscopy (TEM). ER-
SnCV membranes were isolated as a crude microsomal fraction
(CMF) to capture the total ER and SnCV membranes. Since
organelles like nuclei and mitochondria were depleted from
CMF, contaminations from these organelles may originate from
their interaction with the SnCV, such as ER contact sites,
mitochondria-associated membranes or the continuous part of
the nuclear outer membrane. As a ﬁnal quality control, immuno-
blots were used, which revealed a strong enrichment of ER
membranemarker proteins (calnexin, KDEL) and SnCV proteins
(anti-Sn) in the CMF. ER-SnCV membrane puriﬁcation was
performed with approximately 1×108 cells per sample for further
LC-MS/MS measurements.
Salmonella-Modiﬁed Membranes
We deﬁne the sum of host cell membranes that are modiﬁed
by activities of intracellular Sen, such as SCV, SIF, and SIST
membranes as Salmonella-modiﬁed membranes (SMM). The
common feature of SMM is the presence of translocated SPI2-
T3SS eﬀector proteins such as SseF, a membrane-integral protein
localizing to the pathogen vacuole membrane (Muller et al.,
2012). The presence or absence of canonical organelle marker
proteins has been analyzed for the SCV in various previous
studies. Commonly, light microscopy was used to analyze the
presence or absence of such host cell compartment marker
proteins on the SCV. However, due to the diﬀraction limit of light
microscopy, these approaches only provide limited insight into
the spatial organization of the SCV or the biogenesis of SIT, and
thus, alternative methods are required.
A systemic proteomic inventory of the membrane proteomes
of SCV and SIT has been hampered by the lack of eﬃcient
procedures to enrich SCV and SIT membranes by subcellular
fractionation. Such proteomes may provide important clues
to the biogenesis of the pathogen-containing compartment, as
exempliﬁed for L. pneumophila (Urwyler et al., 2009; Hoﬀmann
et al., 2014a). However, the complex tubular arrangement of
SMM renders futile the enrichment by classical subcellular
fractionation. Recently, Vorwerk et al. revised the fractionation
procedure for Salmonella-infected HeLa cells and established
a novel protocol for the isolation and subsequent proteome
analyses of SMM (Vorwerk et al., 2015) (Figure 3E). We used a
three-step approach, in which cell puriﬁcation/lysis is followed
by intracellular compartment enrichment and aﬃnity immuno-
precipitation (IP).
Since the SPI2-T3SS eﬀector SseF is one of the most abundant
Sen components of SMM, we used an epitope-tagged SseF version
as bait for SMM isolation. For this purpose, we constructed a
low-copy expression vector with a C-terminal epitope-tagged
sseF and its cognate chaperone sscB and introduced it in an
sseF-deﬁcient Senmutant strain to avoid eﬀector overproduction
and alteration of the infection process. Expression and co-
localization of the epitope-tagged SseF was visually validated
to exclude impairments of SIF formation. Infection conditions
were optimized for maximum bait expression, and sub-cellular
compartments were separated and harvested by diﬀerential
centrifugation before IP (Vorwerk et al., 2015). With this
approach, a total of 500μg protein was gained from enriched
compartment fractions of 7 × 107 infected host cells (MOI
50, harvested at 8 h p.i.), which was then used for IP using
25μl cross-linked anti-epitope tag labeled magnetic beads. The
eluted samples were analyzed for presence of eﬀector proteins by
Western blot, before proﬁling with LC-MS/MS. In contrast to the
LCV enrichment protocol described above (Urwyler et al., 2009;
Hoﬀmann et al., 2014a), we enriched intracellular compartments
prior to IP of SMM.
Proteomes of Pathogen-Containing
Compartments
Legionella-Containing Vacuoles
The puriﬁed LCVs obtained from Lpn-infected D. discoideum or
RAW 264.7 macrophages by the two-step protocol (immuno-
magnetic separation and density gradient centrifugation)
were subjected to LC-MS/MS (Hoﬀmann et al., 2014a). The
proteomics analysis revealed more than 670 (amoebae) or 1150
(macrophages) host proteins. A large number of these proteins
were implicated in immune responses, signal transduction,
membrane dynamics, lipid metabolism, transport processes, or
cytoskeleton architecture. A comparison of the D. discoideum
and macrophage LCV proteomes indicated an overlap of 16 or
28%, respectively, of the total proteins identiﬁed on the LCV
preparations of the two phagocytes. However, if only proteins
strictly conserved among macrophages and D. discoideum are
compared, e.g. Arf, Sar, and Rab family GTPases involved in
membrane dynamics, the percentage of common LCV proteins
rises to 50%.
Host factors identiﬁed in the LCV proteome included a total
of 14 small Rab GTPases on pathogen vacuoles puriﬁed from
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D. discoideum or macrophages, of which 11 were validated
by ﬂuorescence microscopy (Rab1, Rab2, Rab4, Rab5, Rab7,
Rab8, Rab10, Rab11, Rab14, Rab21, and Rab32). Rab9 was
discovered only by microscopy, and the LCV localization of
Rab6, Rab18 or Rab31 could not be veriﬁed (Hoﬀmann et al.,
2014a). Furthermore, many of these Rab proteins were conﬁrmed
by ﬂuorescencemicroscopy to localize on Lpn vacuoles harboring
wild-type but not icmT mutant L. pneumophila. In addition
to the 12 Rab GTPases, also Arf1, Rap1, Ran, and Rho-related
GTPases were identiﬁed in the LCV proteome. This abundance of
small GTPases corroborates the notion that LCVs communicate
with various cellular signaling and vesicle traﬃcking pathways
(Hoﬀmann et al., 2014a). The depletion of individual GTPases by
RNA interference in epithelial cells indicated that Rab GTPases
involved in endosomal traﬃcking (Rab5a, Rab14, and Rab21)
restrict intracellular growth of Lpn, whereas RabGTPases (Rab8a,
Rab10, and Rab32) implicated in secretory traﬃcking promote
bacterial replication.
Finally, the LCV proteome determined 1 h post infection
revealed Lpn proteins likely required early during intracellular
replication. These include a number of high abundance proteins,
such as ﬂagellin, components of the central metabolism and
bioenergetics machinery, as well as ribosomal and heat shock
proteins. However, also many low abundance proteins were
identiﬁed, including regulatory elements and virulence factors
such as components of the Lsp T2SS or the Icm/Dot T4SS and
as many as 60 Icm/Dot-translocated eﬀectors.
The intriguing discovery of the small GTPase Ran and
its eﬀector RanBP1 in the LCV proteome (Urwyler et al.,
2009), together with the ﬁnding that the Icm/Dot substrate
LegG1 harbors a putative eukaryotic RCC1 Ran GEF domain
(de Felipe et al., 2008; Ninio et al., 2009), led to the
characterization of the Lpn eﬀector protein as the ﬁrst bacterial
Ran activator (Rothmeier et al., 2013). LegG1 localizes to the LCV
membrane, promotes microtubule stabilization and intracellular
LCVmotility as well as replication of Lpn. Moreover, through the
stabilization of microtubules, LegG1 antagonizes the Icm/Dot-
dependent inhibition of chemotactic and random cell migration
(Simon et al., 2014). In summary, the validation and functional
analysis of the proteome of puriﬁed LCVs demonstrates that
the host and pathogen components identiﬁed represent a useful
inventory of factors that play a role in the complex process of
pathogen vacuole formation.
Mycobacterium TDM-Beads Phagosomes
The identiﬁcation of putative host cell-derived interaction
partners of the Mtb virulence-associated cell wall lipid TDM
was facilitated by proteomic analysis of puriﬁed TDM-bead
phagosomes. A hallmark of TDM virulence is its ability to
interfere with phago-lysosomal fusion upon uptake by MO.
This function is also evident, when TDM alone is tested in a
reductionist model of coated beads in vitro.
RAW 264.7 MO were infected with TDM-coated beads,
lysed after 30min, and bead-phagosomes were puriﬁed
(Geﬀken et al., 2015). The dynabead-phagosome preparation
was subjected to LC-MS/MS and analyzed via Sequest and
Scaﬀold 4. In total, 835 proteins were identiﬁed in the TDM-
bead phagosome preparations, of which 542 localized to
intracellular organelles. For instance, 137 or 97 proteins were
predicted mitochondrial or cytoskeletal proteins. 379 were
membrane-associated and predicted to localize with the plasma
membrane (181), ER (97), endosomes (69), and/or Golgi (69),
respectively.
Proteins speciﬁed with the categories ribosome, extracellular
region, Golgi, cytoskeleton, ER, mitochondria, nucleus, and
cytoplasm are potential contaminant proteins, because per
deﬁnition of the gene ontology (GO) terms, these groups do
not comprise proteins that localize in intracellular vesicles
or their membranes. In contrast, the categories intracellular
organelle, organelle part or membrane and organelle membrane
can contain, per GO term deﬁnition, proteins within organized
structure of distinctive morphology and function, occurring
within the cell or associated with membranes thereof. These
categories may be those containing phagosomal or lysosomal
proteins. Therefore, ourmethod to purify control and TDM-bead
phagosomes provides pure bead phagosome preparations with
limited amounts of contaminant proteins, which when present
in high abundances can overwrite signals of proteins of interest
in MS analysis.
Importantly, proteins not classiﬁed as endo- or phagosomal
can still be involved in either direct or indirect interaction with
bead-phagosomes. For example, cytoskeleton proteins have been
identiﬁed prominently in TDM-bead phagosome preparations.
Cytoskeleton elements however, are functional in phagocytosis
and subsequent events during phagosome biogenesis (Flannagan
et al., 2012; Weiss and Schaible, 2015). We recently described the
role of WASH-mediated actin recruitment to the mycobacterial
phagosome as a prerequisite for inhibition of phagosome
maturation and intracellular bacterial growth (Kolonko et al.,
2014). Taken together, our improved puriﬁcation protocol
(Geﬀken et al., 2015), combined with high-resolution MS-based
proteomics, revealed candidates putatively involved in TDM-
bead phagosome formation, and therefore, most likely play a role
forMtb interactions within host MO (Kolonko et al., 2014).
Chlamydia and Simkania Inclusions
Isolated Ctr inclusions and ER-SnCV membranes as well as
control samples were analyzed by LC-MS/MS via Sorcerer. MS
data of four biological replicates of puriﬁed non-infected and
Ctr-infected samples were combined. In total, 2671 proteins
were identiﬁed, of which 2231 were host proteins and 440
were Ctr proteins. About 662 human proteins were reproducibly
found in all samples, of which 102 proteins (36 enriched
and 66 depleted proteins) were diﬀerentially expressed (<0.5
or >2-fold). Protein targets that play a crucial role in the
regulation of host cell metabolism and apoptosis were chosen
for validation studies, because energy acquisition from the
host and inhibiting cell death represent important conditions
for successful Ctr infections (Subbarayal et al., 2015). The
association of these factors with chlamydial inclusion and
their regulation during infection was studied by immuno-
ﬂuorescence microscopy, immuno-blot analysis and RNA
interference.
Analyzing the ER-SnCV LC-MS/MS-data was challenging,
since a large number of host cell proteins were identiﬁed
(Herweg et al., in revision). We combined three biological
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replicates of Sn and non-infected cells in a semi-quantitative
manner. Using this approach, we identiﬁed 1178 human and
302 Simkania proteins in the infected samples. Interestingly, we
identiﬁed many human proteins linked to membrane-enclosed
compartments, including the endomembrane system, envelope
and vesicles, as well as approximately 15% ER-localizing proteins.
Furthermore, proteins of the nucleus, mitochondria, cytosol and
cytoskeleton were also identiﬁed; although contaminations from
co-purifying intact organelles were excluded based on immuno-
blot and TEM validations.
Since the ER represents the origin of protein synthesis,
we expected to identify proteins from diﬀerent cellular
compartments. Nevertheless, most host proteins that were not
associated with the ER-SnCV should be present in similar
amounts in puriﬁed Sn and ER preparations of non-infected
samples, if they are not speciﬁcally modiﬁed by the bacterial
infection. The comparison of Sn-infected and non-infected
samples helped to identify enriched and depleted host cell
factors. Consistent diﬀerences among the three replicates were
considered to reﬂect potential regulatory aspects. Further
analyses demonstrated an eﬀect of seven main transport
pathways on SnCV formation (clathrin, COPI, COPII, ER-to-
Golgi transport, endosomes, exocytosis, recycling endosomes).
Interestingly, we identiﬁed inverse protein regulation regarding
the retrograde and anterograde transport systems. The inﬂuence
of the retrograde transport on SnCV formation was further
validated by immuno-ﬂuorescence, immuno-blot, TEM and life
cell imaging experiments. In the future, a comprehensive RNAi
screen targeting several traﬃcking routes should conﬁrm our
observations. The inﬂuence of additional traﬃcking processes
could complete our understanding of how the SnCV is formed.
Finally, the proteome data also yielded SnCV-speciﬁc and
possibly secreted bacterial factors. These will be used as targets
for immuno-staining of the SnCV in future experiments.
Using epithelial cells or phagocytes, we did not observe cell-
dependent pronounced enrichments or depletions of human
proteins in the SnCV compared to ER. It is possible that Sn is
so well adapted to its niche that major modiﬁcations of the ER
as an organelle central to cell life are avoided. In Sn-infected
cells apoptosis or ER-stress is prevented for many days and
bacterial growth is quite slow (7–12 days per developmental
cycle) (Kahane et al., 2002). While the replication rate is strongly
reduced, the cells do not enter a persistent phase and do not
appear to be stressed. This supports the previously suggested
theory that phagocytes containing Snmay act like a Trojan horse
that silently spreads and distributes the bacteria inside a human
host (Greub and Raoult, 2004).
Salmonella-Modiﬁed Membranes
SMM were enriched by IP from sub-cellular fractionated lysates
of infected host cells and subsequently proﬁled by LC-MS/MS
(Vorwerk et al., 2015). Altogether, 552 host proteins were
reproducibly identiﬁed. As with all IP approaches, we could
not exclude that beside SMM components also other proteins
may be co-isolated. Therefore, we introduced a negative control
for a comparative proteomic approach to eliminate unspeciﬁc
enrichments. To this end, we used the IP-extracted proteome of
a Sen strain deﬁcient for SPI2-T3SS-translocation. Two hundred
and nine proteins from the initially 552 identiﬁed SMM host
proteins were also identiﬁed in this control, reducing the
SMM-speciﬁc proteome to 243 unique host proteins. Thus, we
minimized the number of false-positive identiﬁcations. However,
it may also lead to an increase of false negatives. Nonetheless,
we generated a list of priority SMM targets, of which 11
proteins were found to be part of or interact with SMM using
orthogonal methods such as immuno-staining and live cell
imaging (Vorwerk et al., 2015).
Analyses of the SMM components revealed that proteins
from diﬀerent cellular origins were included in the pathogen-
modiﬁed membranes. In line with previous observations, a
large number of cytoskeletal, endo- and lysosomal, as well
as Golgi and vesicle transport-related proteins were identiﬁed.
Moreover, many proteins previously not considered as present
on SCV and SIF membranes were observed. In addition to
late endosomal compartments already known to interact with
the SCV, the analyses revealed presence of vesicles involved
in ER to Golgi transport, Golgi membranes and various types
of endocytic compartments. For instance, several components
of COPI and COPII-coated vesicles, including CopA, CopG1
(Cop I) and Sec23A and Sar1A (COPII) were found to be part
of the SMM proteome. In addition to components associated
with the anterograde and retrograde transport system, several
proteins involved in ER dynamics such as the small GTPase
Rab10 and Rab2a, ER chaperones (protein disulﬁde-isomerase
PDIA1, PDIA3, PDIA6, endoplasmin, hypoxia up-regulated
protein 1), SNARE proteins (VAMP-associated protein A and
B), vesicle recognition particles (subunit Srp72 and receptor
SrpR), B-cell receptor associated protein 31, as well as diverse
ER membrane proteins (e.g., transitional ER ATPase, calnexin,
cytochrome B5, estradiol 17-beta dehydrogenase, dolichyl-
diphospho-oligosaccharide-glycosyltransferase, transmembrane
protein 43) were identiﬁed, hinting at a direct interaction of
SMM with the ER system. Thus, the proteome inventory of
SMM (Vorwerk et al., 2015) and observations from other studies
indicate that intracellular Sen induce the fusion of various types
of host cell compartments to the SCV and SIT (Drecktrah et al.,
2008; Krieger et al., 2014). Furthermore, components of the
actin cytoskeleton were identiﬁed as well as various proteins
acting as linkers between F-actin and membrane compartments.
In summary, these results indicate that SMM proteomics is
a powerful approach to investigate molecular mechanisms of
Salmonella-host interactions and to develop new intervention
strategies.
By taking control over the host cell’s vesicle fusion machinery,
intracellular Sen create an extensive interconnected system
of vesicles. On the one hand, this network is continuously
interacting with incoming endosomal cargo, providing
nutritional supply for the intracellular pathogen within
SCVs connected to this network. On the other hand, for those
SCV connected to the network, the large lumen results in rapid
dilution of antimicrobial activities delivered during endosomal
maturation to the SCV. This way, the tubular membrane network
fulﬁlls dual requirements for nutrition and protection against
host defense mechanisms.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 11 June 2015 | Volume 5 | Article 48
Herweg et al. Pathogen compartment proteomics
TA
B
LE
1
|M
S
-i
d
en
ti
ﬁ
ed
p
ro
te
in
s
o
b
se
rv
ed
in
Le
g
io
n
el
la
-c
o
nt
ai
ni
ng
va
cu
o
le
s
(L
C
V
),
S
al
m
on
el
la
-m
o
d
iﬁ
ed
m
em
b
ra
ne
s
(S
M
M
),
S
im
ka
n
ia
-c
o
nt
ai
ni
ng
va
cu
o
le
s-
E
R
-m
em
b
ra
ne
s
(S
nC
V-
E
R
),
C
h
la
m
yd
ia
-c
o
nt
ai
ni
ng
va
cu
o
le
s
(C
C
V
)a
nd
M
yc
ob
ac
te
ri
u
m
-p
ha
g
o
so
m
es
(T
D
M
).
#
A
cc
es
si
o
n
P
ro
te
in
A
cc
es
si
o
n
A
cc
es
si
o
n
A
cc
es
si
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
U
ni
P
ro
tA
C
hu
m
an
d
es
cr
ip
ti
o
n
U
ni
P
ro
tI
D
U
ni
P
ro
tI
D
U
ni
P
ro
tI
D
H
eL
a
T
H
P
1
H
eL
a
R
A
W
26
4.
7
hu
m
an
1
m
o
us
e2
d
ic
ti
3
S
nC
V
S
nC
V
C
C
V
T
D
M
1
A
C
LY
AT
P
-c
itr
at
e
sy
nt
ha
se
P
53
39
6
Q
54
YA
0
+
+
+
2
A
LD
O
A
Fr
uc
to
se
-b
is
ph
os
ph
at
e
al
do
la
se
A
P
04
07
5
Q
86
A
67
+
+
+
3
A
R
P
C
4
A
ct
in
-r
el
at
ed
pr
ot
ei
n
2/
3
co
m
pl
ex
su
bu
ni
t4
P
59
99
8
P
59
99
9
O
96
62
5
+
+
+
4
C
1T
M
M
on
of
un
ct
io
na
lC
1-
te
tr
ah
yd
ro
fo
la
te
sy
nt
ha
se
,
m
ito
ch
on
dr
ia
l
Q
6U
B
35
Q
3V
3R
1
+
+
+
5
C
A
P
ZB
F-
ac
tin
-c
ap
pi
ng
pr
ot
ei
n
su
bu
ni
tb
et
a
P
47
75
6
P
47
75
7
+
+
+
6
D
H
B
4
P
er
ox
is
om
al
m
ul
tif
un
ct
io
na
le
nz
ym
e
ty
pe
2
P
51
65
9
P
51
66
0
Q
9N
K
W
1
+
+
+
+
7
D
H
X3
0
P
ut
at
iv
e
AT
P
-d
ep
en
de
nt
R
N
A
he
lic
as
e
D
H
X3
0
Q
7L
2E
3
Q
99
P
U
8
+
+
8
E
F1
B
E
lo
ng
at
io
n
fa
ct
or
1-
be
ta
P
24
53
4
O
70
25
1
Q
9G
R
F8
+
+
+
9
E
F1
G
E
lo
ng
at
io
n
fa
ct
or
1-
ga
m
m
a
P
26
64
1
Q
9D
8N
0
+
+
+
10
E
F2
E
lo
ng
at
io
n
fa
ct
or
2
P
13
63
9
P
58
25
2
P
15
11
2
+
+
+
+
11
IM
D
H
2
In
os
in
e-
5’
-m
on
op
ho
sp
ha
te
de
hy
dr
og
en
as
e
2
P
12
26
8
P
24
54
7
+
+
+
12
M
Y
H
9
M
yo
si
n-
9
P
35
57
9
Q
8V
D
D
5
+
+
+
+
13
P
S
M
D
2
26
S
pr
ot
ea
so
m
e
no
n-
AT
P
as
e
re
gu
la
to
ry
su
bu
ni
t2
Q
13
20
0
Q
8V
D
M
4
+
+
+
+
14
R
M
12
39
S
rib
os
om
al
pr
ot
ei
n
L1
2,
m
ito
ch
on
dr
ia
P
52
81
5
Q
9D
B
15
Q
86
K
A
1
+
+
+
15
R
M
43
39
S
rib
os
om
al
pr
ot
ei
n
L4
3,
m
ito
ch
on
dr
ia
l
Q
8N
98
3
Q
5R
L2
0
+
+
16
R
M
48
39
S
rib
os
om
al
pr
ot
ei
n
L4
8,
m
ito
ch
on
dr
ia
l
Q
96
G
C
5
Q
8J
ZS
9
+
+
17
S
LI
R
P
S
R
A
st
em
-lo
op
-in
te
ra
ct
in
g
R
N
A
-b
in
di
ng
pr
ot
ei
n,
m
ito
ch
on
dr
ia
l
Q
9G
ZT
3
Q
86
I7
L
+
+
18
TC
P
E
T-
co
m
pl
ex
pr
ot
ei
n
1
su
bu
ni
te
ps
ilo
n
P
48
64
3
P
80
31
6
+
+
+
19
TC
P
G
T-
co
m
pl
ex
pr
ot
ei
n
1
su
bu
ni
tg
am
m
a
P
49
36
8
P
80
31
8
+
+
+
+
20
TC
P
Z
T-
co
m
pl
ex
pr
ot
ei
n
1
su
bu
ni
tz
et
a
P
40
22
7
P
80
31
7
+
+
+
21
TE
R
A
Tr
an
si
tio
na
le
nd
op
la
sm
ic
re
tic
ul
um
AT
P
as
e
P
55
07
2
Q
01
85
3
P
90
53
2
+
+
+
22
TI
F1
B
Tr
an
sc
rip
tio
n
in
te
rm
ed
ia
ry
fa
ct
or
1-
be
ta
Q
13
26
3
Q
62
31
8
+
+
+
+
23
D
D
X3
X
AT
P
-d
ep
en
de
nt
R
N
A
he
lic
as
e
D
D
X3
X
O
00
57
1
Q
62
16
7
Q
54
Q
S
3
+
+
+
+
24
M
Y
O
1C
M
yo
si
n-
Ic
O
00
15
9
Q
9W
TI
7
+
+
25
A
N
XA
1
A
nn
ex
in
A
1
P
04
08
3
P
10
10
7
+
+
+
+
26
AT
D
3A
AT
P
as
e
fa
m
ily
A
A
A
do
m
ai
n-
co
nt
ai
ni
ng
pr
ot
ei
n
3A
Q
9N
V
I7
Q
92
5I
1
+
+
27
AT
P
G
AT
P
sy
nt
ha
se
su
bu
ni
tg
am
m
a,
m
ito
ch
on
dr
ia
l
P
36
54
2
Q
91
V
R
2
Q
54
D
F1
+
+
+
+
28
AT
P
O
AT
P
sy
nt
ha
se
su
bu
ni
tO
,m
ito
ch
on
dr
ia
l
P
48
04
7
Q
9D
B
20
Q
54
R
A
8
+
+
+
29
C
A
LX
C
al
ne
xi
n
P
27
82
4
P
35
56
4
Q
55
B
A
8
+
+
+
+
30
C
O
P
G
1
C
oa
to
m
er
su
bu
ni
tg
am
m
a
-1
Q
9Y
67
8
Q
9Q
ZE
5
+
+
+
31
E
N
P
L
E
nd
op
la
sm
in
P
14
62
5
P
08
11
3
+
+
+
+
32
H
Y
O
U
1
H
yp
ox
ia
up
-r
eg
ul
at
ed
pr
ot
ei
n
1
Q
9Y
4L
1
Q
9J
K
R
6
Q
55
6U
6
33
IM
M
T
M
ito
ch
on
dr
ia
li
nn
er
m
em
br
an
e
pr
ot
ei
n
Q
16
89
1
Q
8C
A
Q
8
+
+
+ (C
on
tin
ue
d)
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 12 June 2015 | Volume 5 | Article 48
Herweg et al. Pathogen compartment proteomics
TA
B
LE
1
|C
o
nt
in
ue
d
#
A
cc
es
si
o
n
P
ro
te
in
A
cc
es
si
o
n
A
cc
es
si
o
n
A
cc
es
si
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
D
et
ec
ti
o
n
U
ni
P
ro
tA
C
hu
m
an
d
es
cr
ip
ti
o
n
U
ni
P
ro
tI
D
U
ni
P
ro
tI
D
U
ni
P
ro
tI
D
H
eL
a
T
H
P
1
H
eL
a
R
A
W
26
4.
7
hu
m
an
1
m
o
us
e2
d
ic
ti
3
S
nC
V
S
nC
V
C
C
V
T
D
M
34
M
2O
M
M
ito
ch
on
dr
ia
l2
-o
xo
gl
ut
ar
at
e/
m
al
at
e
ca
rr
ie
r
pr
ot
ei
n
Q
02
97
8
Q
9C
R
62
+
+
35
M
P
C
P
P
ho
sp
ha
te
ca
rr
ie
r
pr
ot
ei
n,
m
ito
ch
on
dr
ia
l
Q
00
32
5
Q
8V
E
M
8
Q
54
B
F6
+
+
+
36
N
B
5R
3
N
A
D
H
-c
yt
oc
hr
om
e
b5
re
du
ct
as
e
3
P
00
38
7
Q
9D
C
N
2
+
+
+
+
37
N
D
U
S
3
N
A
D
H
de
hy
dr
og
en
as
e
[u
bi
qu
in
on
e]
iro
n-
su
lfu
r
pr
ot
ei
n
3
O
75
48
9
Q
9D
C
T2
P
22
23
7
+
+
+
38
N
U
15
5
N
uc
le
ar
po
re
co
m
pl
ex
pr
ot
ei
n
N
up
15
5
O
75
69
4
Q
99
P
88
+
+
+
39
P
D
IA
1
P
ro
te
in
di
su
lﬁ
de
-is
om
er
as
e
P
07
23
7
P
09
10
3
+
+
+
+
40
P
D
IA
3
P
ro
te
in
di
su
lﬁ
de
-is
om
er
as
e
A
3
P
30
10
1
P
27
77
3
Q
54
E
N
4
+
+
+
+
41
P
D
IA
6
P
ro
te
in
di
su
lﬁ
de
-is
om
er
as
e
A
6
Q
15
08
4
Q
86
9Z
0
+
+
+
+
42
P
R
D
X3
Th
io
re
do
xi
n-
de
pe
nd
en
tp
er
ox
id
e
re
du
ct
as
e,
m
ito
ch
on
dr
ia
l
P
30
04
8
P
20
10
8
+
+
+
+
43
R
A
B
10
R
as
-r
el
at
ed
pr
ot
ei
n
R
ab
-1
0
P
61
02
6
P
61
02
7
+
+
+
+
44
R
A
B
14
R
as
-r
el
at
ed
pr
ot
ei
n
R
ab
-1
4
P
61
10
6
Q
91
V
41
P
36
41
0
+
+
+
+
45
R
A
B
2A
R
as
-r
el
at
ed
pr
ot
ei
n
R
ab
-2
A
P
61
01
9
P
53
99
4
P
36
40
9
+
+
+
+
46
R
A
B
5C
R
as
-r
el
at
ed
pr
ot
ei
n
R
ab
-5
C
P
51
14
8
P
35
27
8
+
+
+
+
47
R
A
B
7A
R
as
-r
el
at
ed
pr
ot
ei
n
R
ab
-7
a
P
51
14
9
P
51
15
0
P
36
41
1
+
+
+
+
48
R
A
P
1B
R
as
-r
el
at
ed
pr
ot
ei
n
R
ap
-1
b
P
61
22
4
Q
99
JI
6
P
18
61
3
+
+
+
+
49
R
P
N
2
D
ol
ic
hy
l-d
ip
ho
sp
ho
ol
ig
os
ac
ch
ar
id
e-
pr
ot
ei
n
gl
yc
os
yl
tr
an
sf
er
as
e
su
bu
ni
t2
P
04
84
4
Q
9D
B
G
6
+
+
+
50
S
N
A
A
A
lp
ha
-s
ol
ub
le
N
S
F
at
ta
ch
m
en
tp
ro
te
in
P
54
92
0
Q
9D
B
05
+
+
+
+
51
TF
R
1
Tr
an
sf
er
rin
re
ce
pt
or
pr
ot
ei
n
1
P
02
78
6
Q
62
35
1
+
+
+
+
52
V
IG
LN
V
ig
ilin
Q
00
34
1
Q
8V
D
J3
+
+
+
53
4F
2
4F
2
ce
ll-
su
rfa
ce
an
tig
en
he
av
y
ch
ai
n
P
08
19
5
P
10
85
2
+
+
+
+
54
P
G
R
C
2
M
em
br
an
e-
as
so
ci
at
ed
pr
og
es
te
ro
ne
re
ce
pt
or
co
m
po
ne
nt
2
O
15
17
3
Q
80
U
U
9
+
+
+
55
K
6P
P
6-
ph
os
ph
of
ru
ct
ok
in
as
e
ty
pe
C
Q
01
81
3
Q
9W
U
A
3
+
+
+
56
U
B
A
1
U
bi
qu
iti
n-
lik
e
m
od
iﬁ
er
-a
ct
iv
at
in
g
en
zy
m
e
1
P
22
31
4
Q
02
05
3
+
+
+
+
1,
S
M
M
pr
ot
ei
ns
is
ol
at
ed
fro
m
H
eL
a
(d
at
a
se
t:
(1
));
2,
LC
V
pr
ot
ei
ns
is
ol
at
ed
fro
m
R
A
W
26
4.
7
m
ac
ro
ph
ag
es
(d
at
a
se
t:
(2
);
3,
LC
V
pr
ot
ei
ns
is
ol
at
ed
fro
m
D
ic
ty
os
te
liu
m
st
ra
in
s
(c
om
bi
ne
d
da
ta
se
ts
:(
2,
3)
).
1.
Vo
rw
er
k,
S
.,
K
rie
ge
r,
V
J.
,H
en
se
l,
M
.,
an
d
H
an
sm
ei
er
N
.(
20
14
)P
ro
te
om
es
of
ho
st
ce
lls
m
em
br
an
es
m
od
iﬁ
ed
by
in
tr
ac
el
lu
la
r
ac
tiv
iti
es
of
S
al
m
on
el
la
en
te
ric
a.
M
ol
.C
el
l.
P
ro
te
om
ic
s
14
(1
),
81
-9
2.
2.
H
of
fm
an
n,
C
.,
Fi
ns
el
,I
.,
O
tt
o,
A
.,
P
fa
fﬁ
ng
er
,G
.,
R
ot
hm
ei
er
,E
.,
H
ec
ke
r,
M
.,
et
al
.(
20
13
)F
un
ct
io
na
la
na
ly
si
s
of
no
ve
lR
ab
G
TP
as
es
id
en
tiﬁ
ed
in
th
e
pr
ot
eo
m
e
of
pu
riﬁ
ed
Le
gi
on
el
la
-c
on
ta
in
in
g
va
cu
ol
es
fro
m
m
ac
ro
ph
ag
es
.C
el
l.
M
ic
ro
bi
ol
16
,1
03
4-
52
.
3.
S
he
vc
hu
k,
O
.,
B
at
zi
lla
,C
.,
H
ag
el
e,
S
.,
K
us
ch
,H
.,
En
ge
lm
an
n,
S
.,
H
ec
ke
r,
M
.,
et
al
.(
20
09
)P
ro
te
om
ic
an
al
ys
is
of
Le
gi
on
el
la
-c
on
ta
in
in
g
ph
ag
os
om
es
is
ol
at
ed
fro
m
D
ic
ty
os
te
liu
m
.I
nt
.J
.M
ed
.M
ic
ro
bi
ol
29
9,
48
9-
50
8.
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 13 June 2015 | Volume 5 | Article 48
Herweg et al. Pathogen compartment proteomics
Comparative Proteomics of Pathogen
Compartments
Intracellular development and replication of Legionella,
Mycobacterium, Chlamydia, Simkania, and Salmonella
spp. follow diﬀerent routes, and the bacteria form unique
pathogen-containing vacuoles (PCVs) (Figure 2). The varying
localizations, characteristics and knowledge of the distinct PCVs
required diﬀerent approaches for puriﬁcation of pathogen-
modiﬁed vacuoles and membranes (Figure 3). For LCVs and
SMMs vacuole-speciﬁc pathogen markers were exploited, i.e.,
the bacterial eﬀector proteins SidC or SseF, which allowed
compartment enrichment by immuno-magnetic separation
based on distinct PCV components. The isolation of TDM
bead phagosomes also included a magnetic separation step;
however, in this case magnetic dynabeads covalently coated with
BSA and TDM rather than the whole pathogen or a labeled
PCV were enriched. For LCV and TDM bead phagosome
puriﬁcation density gradient centrifugation was used as a second
puriﬁcation step. Finally, for the puriﬁcation of SMM diﬀerential
centrifugation was used as an additional puriﬁcation step,
and the enrichment of CCVs or SnCVs solely relied on this
separation principle.
Despite the distinct intracellular life-styles and the diﬀerent
technical approaches used, we were able to identify common host
factors pointing to common strategies and interactions between
cellular organelles and PCVs. Importantly, while the puriﬁcation
approaches were diﬀerent for the pathogens, the preparations
were mainly analyzed on the same proteomics platform. The
technical consistency at the level of proteomics analysis is a
major asset for the studies summarized here. The standardized
analytical pipeline allowed drawing conclusions about PCV
formation of the pathogens studied and likely also others.
The comparison of the proteomic data obtained from
enriched LCVs, SMM, CCVs, SnCVs and Mycobacterium
TDM-bead phagosomes yielded a list of 34 common host
factors (Table 1). The presence of host protein components of
endosomal vesicle transport, protein folding and turnover (ER,
T-complex, and ubiquitin-proteasome) as well as mitochondrial
energy metabolism could be conﬁrmed (Figure 4). Interestingly,
more common host proteins were associated with LCVs and
SnCVs (134 proteins, Table S1), SMM and SnCVs (183 proteins,
Table S2) (Vorwerk et al., 2015), or LCVs, SMM and SnCVs (85
proteins, Table S3), compared with LCVs, SMM and CCVs (57
proteins, Table S4). Thus, it seems that in the case of Legionella,
Simkania, and Salmonella the formation of the PCV is more
connected to intracellular vesicle transport processes, including
endosomal, clathrin-dependent, ER-derived, and Golgi-mediated
pathways (Figure 4). Of note, we identiﬁed many similarities
between LCVs and SnCVs, presumably because of their intimate
interactions with the ER (Table S1). Since the SnCV is much
closer connected to the ER than the LCV, unique host factors are
likely to play additional roles.
The impact of ER-dependent protein folding on all PCVs may
be reﬂected in the close association between ER and the PCV
membranes (Gagnon et al., 2002; Tailleux et al., 2003; Isberg
et al., 2009; Derre et al., 2011; Mehlitz et al., 2014). Furthermore,
FIGURE 4 | Conserved components of LCVs, CCVs, SnCVs, and SMMs
visualized using the STRING (Search Tool for Retrieval of Interacting
Genes/Proteins) algorithm. Marked (circles) are clusters comprised of
interacting components from energy metabolism (mitochondria), protein
folding (proteasome), protein folding (ER) and vesicle transport (endosomes).
Lines represent protein-protein interactions with different layers of evidence:
purple: experimental; blue: co-occurrence; red: fusion; black: co-expression;
light blue: database; yellow: text-mining; green: neighborhood.
the association of some PCVs (LCVs, CCVs, SnCVs) with
mitochondria indicated by microscopy and the identiﬁcation
of several mitochondrial proteins is peculiar and may indicate
the common requirement of these intracellular pathogens to
acquire metabolites from these organelles. Association with
mitochondria was already described for Lp, Ctr, and Sn,
which appear to recruit these compartments to the PCV
(Horwitz, 1983; Matsumoto et al., 1991; Abu Kwaik, 1996;
Tilney et al., 2001; Mehlitz et al., 2014). In summary, while
due to their formation processes diﬀerent PCVs comprise a
unique set of components, some host factors as well as the
communication with cell organelles is similar. The composition
of a variety of puriﬁed PCVs described in this work represents
a comprehensive inventory of eukaryotic and bacterial factors
putatively implicated in PCV formation. The challenge lying
ahead is the functional characterization of the host and pathogen
components and their interactions in space and time.
Our studies led to the identiﬁcation of host cell factors
manipulated only by certain pathogens, as well as host factors
that are commonly involved in the formation of PCV by clinically
important intracellular bacteria. The latter group may comprise
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interesting new target structures for new strategies to interfere
with intracellular proliferation. The knowledge of common
mechanisms used for establishing an intracellular niche could
provide new clues how to tackle the intracellular replication of
important bacterial pathogens.
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